Cavo M; Pantani L; Tacchetti P; Pallotti MC; Brioli A; Petrucci A; Zamagni E; Tosi P., Thalidomide maintenance in multiple myeloma: certainties and
controversies., «JOURNAL OF CLINICAL ONCOLOGY», 2009, 27(32), pp. 186 - 187 [replica/breve intervento]
Cavo M.; Zamagni E.; Tacchetti P.; Brioli A.; Pallotti C.; Pantani L.; Ceccolini M.; Petrucci A.; Testoni N.; Terragna C.; Marzocchi G.; Durante S.; Tosi P.; Baccarani M., The road to cure in multiple myeloma: Incorporation of novel agents into autologous stem cell transplantation, «HEMATOLOGY MEETING REPORTS», 2009, 3, pp. 24 - 25 [articolo]
Terpos E; Sezer O; Croucher PI; García-Sanz R; Boccadoro M; San Miguel J; Ashcroft J; Bladé J; Cavo M; Delforge M; Dimopoulos MA; Facon T; Macro M; Waage A; Sonneveld P; European Myeloma Network., The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network., «ANNALS OF ONCOLOGY», 2009, 20(8), pp. 1303 - 1317 [articolo]
Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S., 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone., «IN VIVO», 2008, 22, pp. 513 - 517 [articolo]
San Miguel JF, Schlag R, Khuageva NK, Dimopoulos MA, Shpilberg O, Kropff M,Spicka I, Petrucci MT, Palumbo A, Samoilova OS, Dmoszynska A, Abdulkadyrov KM,Schots R, Jiang B, Mateos MV, Anderson KC, Esseltine DL, Liu K, Cakana A, van de Velde H, Richardson PG; VISTA Trial Investigators [..; Cavo M; ..], Bortezomib plus melphalan and prednisone for initial treatment of multiple
myeloma., «THE NEW ENGLAND JOURNAL OF MEDICINE», 2008, 359, pp. 906 - 917 [articolo]
Tosi P; Terragna C; Testoni N; Zamagni E; Renzulli M; Tacchetti P; Montanari E; Perrone G; Ceccolini M; Brioli A; Pallotti MC; Tura S; Baccarani M; Cavo M., Evaluation of bone disease in multiple myeloma patients carrying the t(4;14) chromosomal translocation., «EUROPEAN JOURNAL OF HAEMATOLOGY», 2008, 80, pp. 31 - 36 [articolo]
Rapezzi C; Riva L; Quarta CC; Perugini E; Salvi F; Longhi S; Ciliberti P;
Pastorelli F; Biagini E; Leone O; Cooke RM; Bacchi-Reggiani L; Ferlini A; Cavo M; Merlini G; Perlini S; Pasquali S; Branzi A, Gender-related risk of myocardial involvement in systemic amyloidosis, «AMYLOID», 2008, 15(1), pp. 40 - 48 [articolo]
Ludwig H; Durie BG; Bolejack V; Turesson I; Kyle RA; Blade J; Fonseca R;
Dimopoulos M; Shimizu K; San Miguel J; Westin J; Harousseau JL; Beksac M;
Boccadoro M; Palumbo A; Barlogie B; Shustik C; Cavo M; Greipp PR; Joshua D; AttalM; Sonneveld P; Crowley J., Myeloma in patients younger than age 50 years presents with more favorable
features and shows better survival: an analysis of 10 549 patients from the
International Myeloma Working Group., «BLOOD», 2008, 115, pp. 4039 - 4047 [articolo]
Palumbo A; Bringhen S; Liberati AM; Caravita T; Falcone A; Callea V; MontanaroM; Ria R; Capaldi A; Zambello R; Benevolo G; Derudas D; Dore F; Cavallo F; Gay F;Falco P; Ciccone G; Musto P; Cavo M; Boccadoro M., Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial, «BLOOD», 2008, 112, pp. 3107 - 3114 [articolo]
Palumbo A, Rajkumar SV, Dimopoulos MA, Richardson PG, San Miguel J, Barlogie B, Harousseau J, Zonder JA, Cavo M, Zangari M, Attal M, Belch A, Knop S, JoshuaD, Sezer O, Ludwig H, Vesole D, Bladé J, Kyle R, Westin J, Weber D, Bringhen S,Niesvizky R, Waage A, von Lilienfeld-Toal M, Lonial S, Morgan GJ, Orlowski RZ,Shimizu K, Anderson KC, Boccadoro M, Durie BG, Sonneveld P, Hussein MA;International Myeloma Working Group., Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma., «LEUKEMIA», 2008, 22, pp. 414 - 423 [articolo]
Cavo M.; Pallotti M.C.; Pantani L.; Petrucci A.; Brioli A.; Terragna C.; Testoni N.; Marzocchi G.; Durante S.; Ceccolini M.; Perrone G.; Tacchetti P.; Zamagni E.; Tosi P.; Baccarani M., Proteasome inhibitors: Bortezomib in multiple myeloma, «HEMATOLOGY MEETING REPORTS», 2008, 2, pp. 127 - 132 [articolo]
SanMiguel J; Facon T; Cavo M., Recent phase III trials in the frontline treatment of multiple myeloma: evaluating their impact on community practice., «CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY», 2008, 6, pp. s4 - s10 [articolo]
CAVO M; ATTAL M; GERTZ MA; GIRALT S; LUDWIG H; MORGAN GJ; ANDERSON KC., The current landscape of multiple myeloma treatment, «LEUKEMIA RESEARCH», 2008, 32, pp. S1 - S2 [articolo]
Hussein M.A.;Vrionis F.D.;Allison R.;Berenson J.;Berven S.;Erdem E.;Giralt S.;Jagannath S.;Kyle R.A.;LeGrand S.;Pflugmacher R.;Raje N.;Rajkumar S.V.;Randall R.L.;Roodman D.;Siegel D.;Vescio R.;Zonder J.;Durie B.G.;International Myeloma Working Group [..; Cavo M; ..], The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement., «LEUKEMIA», 2008, 22, pp. 1479 - 1484 [articolo]
Nanni C; Zamagni E; Cavo M; Rubello D; Tacchetti P; Pettinato C; Farsad M; Castellucci P; Ambrosini V; Montini GC; Al-Nahhas A; Franchi R; Fanti S., 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma., «WORLD JOURNAL OF SURGICAL ONCOLOGY», 2007, 5, pp. 68 - 68 [articolo]
